Quality organizations have moved from being reactive to becoming more proactive. Now, with AI, the next evolution is becoming ...

The Singapore training course is part of an ongoing IAEA regional project to support energy planning. In 2027, participating ...

After sitting through the full presentation on the Phase 3 INTerpath-001 trial at the ESMO Congress over the weekend, ...

BioVie Inc. (NASDAQ: BIVI) (?BioVie? or the ?Company?) announced the Company has been invited to present at the 2026 RECOVER?Treating Long COVID (RECOVER-TLC) Hybrid Workshop, hosted by the National ...

Tegoprubart-treated patients demonstrated a mean improvement on the total MTSOSD-59R symptom occurrence scale at 12 months while tacrolimus-treated patients experienced a mean worsening of symptom occ ...

The Taylor City Council has approved a development agreement that could pave the way for a 664-acre data center campus just outside city limits, raising questio ...

Eledon Pharmaceuticals, Inc. (?Eledon?) (Nasdaq: ELDN) announced new positive patient-reported outcomes data from the Phase 2 BESTOW clinical trial of tegoprubart, its novel investigational ...

Tegoprubart-treated patients demonstrated a mean improvement on the total MTSOSD-59R symptom occurrence scale at 12 months ...

For patients with desmoid tumors, treatment goals extend beyond tumor shrinkage to include symptom relief and improved physical function,” said Bob Lechleider, M.D., Chief Medical Officer of Immunome.

These data support the advancement of FT819 into the ongoing Phase 2 RECLAIM-LN study (FT819-201; NCT07570862) in patients with refractory, moderate-to-severe SLE with lupus nephritis, which uses the ...

Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative ...

(9926.HK) ("Akeso" or the "Company") announced that at the 2025 ESMO Asia Congress, updated results from the pivotal Phase ...